Avidity Biosciences, Inc.

NASDAQ:RNA

30.5 (USD) • At close January 3, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income -80.397-70.793-68.855-60.443-52.358-47.025-52.394-50.471-43.599-45.69-34.235-38.538-29.274-26.353-23.844-16.275-11.439-10.556-6.085-10.401-6.668-5.116-2.549
Depreciation & Amortization 0.710.6870.6410.6150.5660.5290.3910.3810.370.3220.3140.2080.1760.1470.1080.1150.1010.0740.0830.0830.0840.0880.093
Deferred Income Tax 000-8.718-2.966-2.84000000000000.07500.0010-0.0010
Stock Based Compensation 14.09212.81210.3069.8459.829.4539.1047.3077.0866.5086.2384.5164.554.2893.7011.8781.2960.6870.4490.3510.0220.0160.017
Change In Working Capital 6.005-4.059-10.3468.8977.413-10.656-4.5254.3934.2232.565-2.0557.5073.748-6.2470.331.20.9291.894-1.6910.421-0.71519.438-0.021
Accounts Receivables 00000000000000000000000
Change In Inventory 00000000000000000000000
Change In Accounts Payables 8.6753.4722.5752.3570.228-1.9741.15818.3155.4461.6254.9576.0433.29-1.8112.395.7492.4651.8120.0960.3590.291-0.115-0.084
Other Working Capital -2.67-7.531-12.91566.547.185-8.682-5.683-13.922-1.223-1.084-7.0121.4643.748-6.247-2.06-4.5490.9291.894-1.6910.421-0.71519.438-0.021
Other Non Cash Items -6.025-3.6516.8816.3050.7340.732-1.543-0.799-0.0390.690.1640.0920.0180.0290.0240.0091.6650.0350.1044.5261.3921.0550.374
Operating Cash Flow -65.615-65.004-70.3816.501-36.791-49.807-48.967-39.189-31.959-35.546-29.574-26.215-20.782-28.135-19.681-13.073-9.113-7.791-7.14-5.019-5.88515.48-2.086
Investing Activities:
Investments In Property Plant And Equipment -1.704-0.531-0.915-0.863-0.923-0.622-1.82-0.850.107-1.322-0.758-1.707-0.8-0.708-0.525-0.237-0.8450-0.01-0.091-0.014-0.130
Acquisitions Net 000-51.90330.556-46.671193.8621.525-10.825007.30400000000000
Purchases Of Investments -622.434-372.543-141.557-53.807-131.791-24.054-251.35-89.648-53.625-37.847-174.717-85.357000-6.6930000000
Sales Maturities Of Investments 141.72598.205109.725105.71101.23570.72557.4982.7364.4521.5250303.58000000000
Other Investing Activites 00-31.83251.903-30.55646.671-193.86-21.52510.825-16.322-174.717-7.30403.580-6.6930000000
Investing Cash Flow -482.413-274.869-32.74751.04-31.47946.049-195.68-7.76810.932-17.644-175.475-84.064-0.82.872-0.525-6.93-0.8450-0.01-0.091-0.014-0.130
Financing Activities:
Debt Repayment 00000000000000000-3.983-0.7-0.718.75114.2753.783
Common Stock Issued 465.154433.049244.24131.8910.0438.10622.441239.93339.31738.28124.10320.339165.60.4230.01700298.0640.0160.0650-0.0390.039
Common Stock Repurchased 0000000000000000.4440000-0.00500
Dividends Paid 0000000000000000000-0.106000
Other Financing Activities -122.6913.675145.20431.8910.040.8660.523.7210.3030.5030.010.375-10.4280.4130.0170.45-1.346-22.4712.00772.565-19.4630.0630
Financing Cash Flow 342.464446.724389.44531.8910.0438.97222.961243.65439.6238.78424.11320.714155.1720.4130.0170.45-1.346271.611.32371.824-0.71214.2993.822
Other Information:
Effect Of Forex Changes On Cash 00000000000000000000000
Net Change In Cash -205.564104.351286.31899.432-68.2335.214-221.686196.69718.593-14.406-180.936-89.565133.59-24.85-20.189-19.553-11.304263.819-5.82766.714-6.61129.6491.736
Cash At End Of Period 372.982575.751471.4185.08285.945154.175118.961340.647143.95125.357139.763320.699410.264276.674301.524321.713341.266352.5788.75194.57827.86434.4754.826